The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Friedberg Ezra M | Director | Sell(S) | 224 | $27.12 | $6K |
| Jun 15, 2026 | Friedberg Ezra M | Director | Sell(S) | 59 | $27.94 | $2K |
| Jun 11, 2026 | Davis Todd C | Director | Buy(P) | 35K | $27.80 | $986K |
| Jun 11, 2026 | Davis Todd C | Director | Buy(P) | 503 | $28.73 | $14K |
| Dec 23, 2025 | Einhorn Andrew J. | Director | Grant(A) | 12K | — | — |
| Dec 17, 2025 | Ligand Pharmaceuticals Inc | Director, 10% Owner | Disposed to issuer(D) | 0 | — | — |
| Dec 17, 2025 | Ligand Pharmaceuticals Inc | Director, 10% Owner | Grant(A) | 0 | — | — |
| Dec 10, 2025 | Pauls Matthew | Director | Gift(G) | 10K | — | $0 |
| Nov 25, 2025 | Friedberg Ezra M | Director | Sell(S) | 6K | $28.00 | $168K |
| Nov 25, 2025 | Friedberg Ezra M | Director | Sell(S) | 2K | $28.01 | $56K |
| Nov 25, 2025 | Friedberg Ezra M | Director | Sell(S) | 1 | $28.50 | $29 |
| Nov 25, 2025 | Friedberg Ezra M | Director | Sell(S) | 2K | $28.14 | $56K |
| Nov 6, 2025 | Ligand Pharmaceuticals Inc | Director, 10% Owner | Grant(A) | 0 | $9,000,000.00 | $0 |
| Oct 2, 2025 | Pauls Matthew | Director | Option exercise(M) | 2K | — | $0 |
| Oct 2, 2025 | Pauls Matthew | Director | Option exercise(M) | 2K | — | $0 |
| Jul 2, 2025 | Pauls Matthew | Director | Option exercise(M) | 8K | — | $0 |
| Jul 2, 2025 | Pauls Matthew | Director | Option exercise(M) | 8K | — | $0 |
| Jul 2, 2025 | Malamut Richard | Director | Grant(A) | 58K | — | — |
| Jul 2, 2025 | Malamut Richard | Director | Grant(A) | 19K | — | — |
| Jul 2, 2025 | Friedberg Ezra M | Director | Grant(A) | 19K | — | — |
| Jul 2, 2025 | Friedberg Ezra M | Director | Grant(A) | 58K | — | — |
| Jul 2, 2025 | Davis Todd C | Director | Grant(A) | 19K | — | — |
| Jul 2, 2025 | Davis Todd C | Director | Grant(A) | 58K | — | — |
| Jul 2, 2025 | Francis Knuettel II | CFO, Treas & Secty | Grant(A) | 33K | — | — |
| Jul 2, 2025 | Francis Knuettel II | CFO, Treas & Secty | Grant(A) | 102K | — | — |
| Jul 2, 2025 | Pauls Matthew | Director | Grant(A) | 25K | — | — |
| Jul 2, 2025 | Pauls Matthew | Director | Grant(A) | 78K | — | — |
| Jul 2, 2025 | Greenleaf Peter | Director | Grant(A) | 78K | — | — |
| Jul 2, 2025 | Greenleaf Peter | Director | Grant(A) | 25K | — | — |
| Jul 2, 2025 | Baxter Richard B | Director | Grant(A) | 19K | — | — |
| Jul 2, 2025 | Baxter Richard B | Director | Grant(A) | 58K | — | — |
| Jul 2, 2025 | Rangarao Sai | Chief Commercial Officer | Grant(A) | 31K | — | — |
| Jul 2, 2025 | Rangarao Sai | Chief Commercial Officer | Grant(A) | 93K | — | — |
| Jul 2, 2025 | Plesha Scott M. | CEO and President, Director | Grant(A) | 84K | — | — |
| Jul 2, 2025 | Plesha Scott M. | CEO and President, Director | Grant(A) | 255K | — | — |
| Jul 1, 2025 | Ligand Pharmaceuticals Inc | 10% Owner | Conversion(C) | 1.5M | $10.00 | $15.0M |
| Jul 1, 2025 | Ligand Pharmaceuticals Inc | 10% Owner | Other(J) | 31K | — | — |
| Jul 1, 2025 | Ligand Pharmaceuticals Inc | 10% Owner | Conversion(C) | 15K | — | $0 |
| Jul 1, 2025 | Davis Todd C | Director, 10% Owner | Conversion(C) | 1.5M | $10.00 | $15.0M |
| Jul 1, 2025 | Davis Todd C | Director, 10% Owner | Conversion(C) | 15K | — | $0 |
| Jul 1, 2025 | Davis Todd C | Director, 10% Owner | Other(J) | 31K | — | — |
| Jul 1, 2025 | Francis Knuettel II | Chief Financial Officer | Conversion(C) | 10K | $10.00 | $100K |
| Jul 1, 2025 | Francis Knuettel II | Chief Financial Officer | Conversion(C) | 10K | — | $0 |
| Jul 1, 2025 | Francis Knuettel II | Chief Financial Officer | Other(J) | 10K | — | $0 |
| Jul 1, 2025 | Friedberg Ezra M | Director | Conversion(C) | 40K | $10.00 | $400K |
| Jul 1, 2025 | Friedberg Ezra M | Director | Conversion(C) | 40K | $10.00 | $400K |
| Jul 1, 2025 | Friedberg Ezra M | Director | Buy(P) | 40K | — | $0 |
| Jul 1, 2025 | Friedberg Ezra M | Director | Buy(P) | 40K | — | $0 |
| Jul 1, 2025 | Friedberg Ezra M | Director | Conversion(C) | 40K | — | $0 |
| Jul 1, 2025 | Friedberg Ezra M | Director | Conversion(C) | 40K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).